Substance Withdrawal Syndrome

"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Descriptor ID	D013375
MeSH Number(s)	C25.775.835 F03.900.825
Concept/Terms	Substance Withdrawal Syndrome Substance Withdrawal Syndrome Substance Withdrawal Syndromes Syndrome, Substance Withdrawal Syndromes, Substance Withdrawal Withdrawal Syndrome, Substance Withdrawal Syndromes, Substance Withdrawal Symptoms Withdrawal Symptoms Symptom, Withdrawal Symptoms, Withdrawal Withdrawal Symptom Drug Withdrawal Symptoms Drug Withdrawal Symptoms Drug Withdrawal Symptom Symptom, Drug Withdrawal Symptoms, Drug Withdrawal Withdrawal Symptom, Drug Withdrawal Symptoms, Drug

Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Substance Withdrawal Syndrome [C25.775.835]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Substance Withdrawal Syndrome [F03.900.825]

Below are MeSH descriptors whose meaning is related to "Substance Withdrawal Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.

Bar chart showing 47 publications over 20 distinct years, with a maximum of 5 publications in 2012 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	0	3
1997	2	0	2
2002	1	1	2
2003	2	1	3
2005	0	3	3
2006	1	1	2
2008	0	1	1
2009	1	0	1
2010	1	0	1
2011	1	2	3
2012	4	1	5
2013	0	1	1
2014	3	0	3
2016	1	1	2
2018	2	2	4
2019	0	1	1
2021	2	0	2
2022	5	0	5
2023	2	0	2
2024	0	1	1

Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.

Iyer NS, Ferguson EB, Yan VZ, Hand DJ, Abatemarco DJ, Boelig RC. Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study. J Addict Med. 2024 Nov-Dec 01; 18(6):670-674.

View in: PubMed
Stern SJ, D'Orazio JL, Work BD, Calcaterra SL, Thakrar AP. Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal? J Hosp Med. 2024 04; 19(4):339-343.

View in: PubMed
Quezada M, Ponce C, Berr?os-C?rcamo P, Santapau D, Gallardo J, De Gregorio C, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Andr?s-Herrera P, Hip?lito L, Ezquer F. Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence. CNS Neurosci Ther. 2024 04; 30(4):e14517.

View in: PubMed
Quintanilla ME, Quezada M, Morales P, Berr?os-C?rcamo P, Santapau D, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence. Transl Psychiatry. 2022 11 04; 12(1):462.

View in: PubMed
Polintan ETT, Danganan LML, Cruz NS, Macapagal SC, Catahay JA, Patarroyo-Aponte G, Azmaiparashvili Z, Lo KB. Adjunctive Dexmedetomidine in Alcohol Withdrawal Syndrome: A Systematic Review and Meta-analysis of Retrospective Cohort Studies and Randomized Controlled Trials. Ann Pharmacother. 2023 06; 57(6):696-705.

View in: PubMed
Zavodnick J, Heinsinger NM, Lepore AC, Sterling RC. Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management. J Addict Med. 2023 Jan-Feb 01; 17(1):e57-e63.

View in: PubMed
Sweeny L, Slijepcevic A, Curry JM, Philips R, Bonaventure CA, DiLeo M, Luginbuhl AJ, Crawley MB, Guice KM, McCreary E, Buncke M, Petrisor D, Wax MK. Factors Impacting Discharge Destination Following Head and Neck Microvascular Reconstruction. Laryngoscope. 2023 01; 133(1):95-104.

View in: PubMed
Khatri UG, Lee K, Lin T, D'Orazio JL, Patel MS, Shofer FS, Perrone J. A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD). J Med Toxicol. 2022 07; 18(3):205-213.

View in: PubMed
Schmitz NS, Krach LE, Coles LD, Schrogie J, Cloyd JC, Kriel RL. Characterizing Baclofen Withdrawal: A National Survey of Physician Experience. Pediatr Neurol. 2021 09; 122:106-109.

View in: PubMed
O'Sullivan SJ, Schwaber JS. Similarities in alcohol and opioid withdrawal syndromes suggest common negative reinforcement mechanisms involving the interoceptive antireward pathway. Neurosci Biobehav Rev. 2021 06; 125:355-364.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement